Back
ResMed Quote, Financials, Valuation and Earnings
Sponsored
RMD
Sponsored
The little-known AI stock you need to read about now...
Get the name - FREE.
Buy
52
RMD
ResMed
Last Price:
215.92
Seasonality Move:
7.36%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to SeeResMed Price Quote
$215.92
-1.97 (-0.9%)
(Updated: May 14, 2024 at 3:55 PM ET)
ResMed Key Stats
Buy
52
ResMed (RMD)
is a Buy
Day range:
$213.82 - $219.40
52-week range:
$132.24 - $232.99
Dividend yield:
0.88%
P/E ratio:
35.78
P/S ratio:
7.01
P/B ratio:
6.91%
Volume:
780.5K
Avg. volume:
1.2M
1-year change:
-6.69%
Market cap:
$32B
Revenue:
$4.2B
EPS:
$6.51
How Much Does ResMed Make?
Is ResMed Growing As A Company?
ResMed Stock Price Performance
What Is ResMed 52-Week High & Low?
ResMed Price To Free Cash Flow
-
Is ResMed Stock Overvalued?
ResMed is trading at a price to free cash flow ratio of 30.00 -
Is ResMed Stock Undervalued?
ResMed EV to Free Cash Flow ratio is 30.60 -
What Is ResMed’s Price Earnings Growth Ratio?
RMD PEG ratio is 3.07 -
Is ResMed Trading At A Premium To Earnings?
ResMed EV to EBIT ratio is 25.43
Is It Risky To Buy ResMed?
Is ResMed Cash Flow Positive?
ResMed Return On Invested Capital
ResMed Earnings Date & Stock Price
-
What Is ResMed's Stock Price Today?
A single share of RMD can be purchased today for 217.89 -
What Is ResMed’s Stock Symbol?
ResMed trades on the nyse under the ticker symbol: RMD -
When Is ResMed’s Next Earnings Date?
The next quarterly earnings date for ResMed is scheduled on August 2, 2024 -
When Is RMD's next ex-dividend date?
ResMed's next ex-dividend date is May 8, 2024 -
How To Buy ResMed Stock?
You can buy ResMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ResMed Competitors
ResMed Dividend Yield
ResMed Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 29.11% | 11.68% |
Revenue: | 7.17% | 2.12% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 5 |
Sell Recommendations: | 0 |
Price Target: | 216.65 |
Downside from Last Price: | -0.57% |